The Latest Breaking News from FDA

Trump warns thousands of pharma companies over "deceptive ads"

The FDA said it's sending out 100 cease-and-desist letters and warning thousands of others over ads it says are "misleading."

Axios · Sep 10, 2025

10 Times Brands Promised “Lower Sugar” But Didn’t Deliver

We all celebrate when a product boasts “lower sugar,” thinking we’re making a healthier choice—only to be disappointed (and maybe even misled). The promise of sweetness with less cost to our health feels smart, but in many cases, it’s more marketing than truth. From sneaky labeling to lawsuits over deceptive…

Grocery Coupon Guide · Sep 9, 2025

What’s Behind the Sudden Rise in “Plant-Based” Labels—With No Plants?

Have you ever grabbed a product labeled “plant-based,” expecting something leafy, only to find it’s greenwashed marketing—not actual plants? You’re not alone. The trend of plant-based labels with no plants is growing fast and causing plenty of confusion for shoppers. Understanding why this happens—from marketing spin to lax regulation—can help…

Grocery Coupon Guide · Sep 9, 2025

Advocates of MDMA-Assisted Psychotherapy Complain that 'the FDA Moved the Goalposts'

The agency's puzzling concerns about the Lykos Therapeutics drug application

Reason · Sep 8, 2025

As Covid surges in the US, Americans can’t get vaccinated: ‘terrified I might kill somebody’

The FDA is allowing the vaccine for people 65 and older, but younger people need to have an underlying condition

The Guardian - US · Sep 8, 2025

FDA To Expedite Nicotine Pouch Reviews In Pilot Program Under Trump Pressure: Report

The U.S. Food and Drug Administration (FDA) is reportedly set to launch a pilot program to fast-track the review of nicotine pouches from four major tobacco companies amid mounting pressure from the Trump administration.

Benzinga · Sep 8, 2025

FDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines List

The U.S. Food and Drug Administration on Friday established a "green list" import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.

Benzinga · Sep 7, 2025

Two brothers have the same genetic disorder. Their insurance only covered life-altering treatment for one of them

Exclusive: Alison Joseph's sons Noah and Hunter both have Duchenne muscular dystrophy. She tells Rhian Lubin the heartbreaking reality of watching one thrive while the other suffers

The Independent UK · Sep 7, 2025

Maryland screwworm case has US officials bracing for return of an old foe

Rise in cases south of the border prompts concern over US livestock as Trump budget cuts hit research and foreign aid

The Guardian - US · Sep 7, 2025

LSD shows promise for reducing anxiety, shows drugmaker's study

The psychedelic drug LSD showed positive results for easing symptoms in people with generalised anxiety disorder, a recent study has shown.

Euronews · Sep 6, 2025